[Ip-health] [ip-reg-strat-grp] Industry-Led Tiered Pricing or Country-Led Real, Equitable Access - Global Fund's Task Force Proposal Gets Worse Instead of Better
rosettem at heps.or.ug
Mon Mar 31 08:32:57 PDT 2014
This is very unfortunate. partners from Low and middle income need to join
forces and send clear messages to Global Fund that anything that threatens
access in anyway is unacceptable
On Fri, Mar 28, 2014 at 3:49 PM, Baker, Brook <b.baker at neu.edu> wrote:
> Industry-Led Tiered Pricing or Country-Led Real, Equitable Access -
> Global Fund's Task Force Proposal Gets Worse Instead of Better, Prof. Brook
> K. Baker, March 26, 2014
> On or about March 18, 2014, a third draft of the renamed "equitable
> access" proposal was released by Mark Dybul, Executive Director of the
> Global Fund, to partners for further input. If anything, this third draft,
> the text of which is attached , is worse than the previous two drafts:
> - The equitable access objectives of the Task Force are less
> tiered-pricing centric, but tiered pricing is still hard-wired in as the
> single solution that the proponents continue to champion.
> - A key intervention mentioned in the second draft has been deleted,
> namely IP reform and increased and coordinated use of TRIPS public health
> flexibilities. This is an intentional exclusion and cannot be justified -
> overcoming IP barriers is in many circumstances to only way to increase
> - Most of the proposal addresses the needs of poor people in MICs as
> if the problem of access to needed health products has been met in LICs,
> which is clearly untrue.
> - The focus on "basic" medicines only is highly undesirable. The
> focus should be on all needed medicines, including medicines for
> infectious diseases, childhood diseases, neglected diseases, chronic and
> non-communicable diseases, etc.
> - Low- and middle-income governments should be in the driver's seat in
> articulating needs, solutions, and flexibilities; they are inappropriately
> excluded from input in the concept paper that will guide the Task Force.
> - Private industry's interests are unduly reflected in this draft and
> industry inappropriately has a key place on the Task Force; instead,
> originators and generics should be excluded except with respect to
> - Other listed partners have been given an illusory and bizarre option
> of presenting one issue that needs to be addressed as a means of ensuring
> their buy-in to the Task Force proposal; this is not an evidence-based way
> to develop a well-considered list of equitable access options.
> - The idea of a WTO enforcement mechanism has been dropped but the WTO
> is still inappropriately listed as an interested institution.
> Listed partners and countries should rebel against this ill-conceived
> top-down proposal and insist on a country-led process that considers the
> broad range of options available to countries to ensure equitable access to
> affordable medicines needed for all health conditions.
> You received this message because you are subscribed to the Google Groups
> "IP REGIONAL STRATEGIC GROUP." group.
> To unsubscribe from this group and stop receiving emails from it, send an
> email to ip-regional-strategic-group+unsubscribe at googlegroups.com.
> For more options, visit https://groups.google.com/d/optout.
*DOING WHAT YOU LIKE IS FREEDOM. I AM FREE. ARE YOU FREE?*
Rosette C Mutambi, Executive Director
Coalition for Health Promotion and Social Development (HEPS-Uganda)
Making Health Rights and Health Responsibilities a Reality
Plot 351A Balintuma road, Nakulabye Kampala
Tel.: +256-414-270 970 Email: rosettem at heps.or.ug
More information about the Ip-health